Large-scale production and concentration of human lymphoid interferon. 1979

F Klein, and R T Ricketts, and W I Jones, and I A DeArmon, and M J Temple, and K C Zoon, and P J Bridgen

A stable and predictable production system is described for pilot plant quantities (milligram) of human lymphoid interferon, using suspension culture of an African Burkitt's lymphoma derived cell line Namalva with induction by Newcastle disease virus, B-1 strain. Cell cultures were grown in impeller-driven 50-liter fermentors with dilution of the postinduction culture using serum-free medium. High levels of dissolved oxygen were necessary for optimum cell growth. A total of 4,207 liters of interferon culture was produced in a series of 116 fermentor runs. An average yield of 3.5 log(10) international units of interferon per ml was realized before processing. Trichloroacetic acid was used to precipitate the interferon. An average of 3.35 log(10) international units of interferon per ml was recovered in the final nonpurified product.

UI MeSH Term Description Entries
D007372 Interferons Proteins secreted by vertebrate cells in response to a wide variety of inducers. They confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions. Interferon
D008221 Lymphoid Tissue Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS. Lymphatic Tissue,Lymphatic Tissues,Lymphoid Tissues,Tissue, Lymphatic,Tissue, Lymphoid,Tissues, Lymphatic,Tissues, Lymphoid
D009522 Newcastle disease virus The most well known avian paramyxovirus in the genus AVULAVIRUS and the cause of a highly infectious pneumoencephalitis in fowl. It is also reported to cause CONJUNCTIVITIS in humans. Transmission is by droplet inhalation or ingestion of contaminated water or food. Avian Paramyxovirus 1,Paramyxovirus 1, Avian
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

F Klein, and R T Ricketts, and W I Jones, and I A DeArmon, and M J Temple, and K C Zoon, and P J Bridgen
January 1986, Methods in enzymology,
F Klein, and R T Ricketts, and W I Jones, and I A DeArmon, and M J Temple, and K C Zoon, and P J Bridgen
January 1981, Methods in enzymology,
F Klein, and R T Ricketts, and W I Jones, and I A DeArmon, and M J Temple, and K C Zoon, and P J Bridgen
December 1980, Cancer treatment reviews,
F Klein, and R T Ricketts, and W I Jones, and I A DeArmon, and M J Temple, and K C Zoon, and P J Bridgen
January 1983, Rivista di biologia,
F Klein, and R T Ricketts, and W I Jones, and I A DeArmon, and M J Temple, and K C Zoon, and P J Bridgen
January 1980, Journal of interferon research,
F Klein, and R T Ricketts, and W I Jones, and I A DeArmon, and M J Temple, and K C Zoon, and P J Bridgen
January 1981, Acta microbiologica Academiae Scientiarum Hungaricae,
F Klein, and R T Ricketts, and W I Jones, and I A DeArmon, and M J Temple, and K C Zoon, and P J Bridgen
January 1986, Methods in enzymology,
F Klein, and R T Ricketts, and W I Jones, and I A DeArmon, and M J Temple, and K C Zoon, and P J Bridgen
October 1977, The Journal of biological chemistry,
F Klein, and R T Ricketts, and W I Jones, and I A DeArmon, and M J Temple, and K C Zoon, and P J Bridgen
January 1977, Texas reports on biology and medicine,
F Klein, and R T Ricketts, and W I Jones, and I A DeArmon, and M J Temple, and K C Zoon, and P J Bridgen
January 1981, Developments in biological standardization,
Copied contents to your clipboard!